Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

2 Aug 2016 07:00

RNS Number : 9017F
Barr(A.G.) PLC
02 August 2016
 

IMMEDIATE RELEASE 2 August 2016

A.G. BARR p.l.c. 

Trading Update 

A.G. BARR p.l.c. ("A.G. BARR"), which produces and markets some of the UK's leading brands, including IRN-BRU, Rubicon, Strathmore and Funkin, announces a trading update in respect of the six months to 30 July 2016.

In the six month period the UK soft drinks market performance has been challenging with continued deflation and volume declines. Latest available data from IRI, covering the period 31 January to 19 June 2016, shows value down 0.8% whilst volume declined by 0.4%, and indications are that the poor weather across the full month of June and into July will further adversely impact the total market performance. Consequently trading has been highly competitive but, despite this difficult market backdrop, we have maintained both value and volume overall market share. We anticipate revenue in the period of £125m, down 2.9% year on year on a like for like* basis.

Consumer preferences have continued to develop and we have successfully advanced our response to these long term trends. In the period we have announced a new IRN-BRU zero sugar variant and launched three major new lower sugar products. Our new products are all showing encouraging early signs with both customers and consumers, and are positive additions to our broadening portfolio.

Despite the challenging market conditions we have remained focused on delivering against our strategy, launching relevant new products, closely controlling costs, managing risk and ensuring we generate strong free cash flow. Our recent Business Process Redesign investment is already producing customer service benefits and we have continued to invest for the long term in our assets and infrastructure.

Highlights in the period

● A full IRN-BRU brand redesign

● Continued reduced sugar innovation and reformulation across our portfolio:

○ The announcement of IRN-BRU XTRA, a new zero sugar variant

○ Two lower/no sugar launches across our Rubicon brand - Rubicon Light & Fruity and Rubicon Spring

○ Three Snapple Iced Tea flavours reformulated to no added sugar variants

● Strong performance from both Funkin and our International business

● New £5m glass bottling line at Cumbernauld now operational, allowing in-house production of Snapple and offering future new product development potential

● Closure of the Defined Benefit Pension Scheme to future accrual

 

Outlook

The decision of the United Kingdom to leave the European Union has resulted in a degree of economic uncertainty and a weakening of Sterling. The impact of weaker Sterling will not have a significant impact in 2016, but it is anticipated input costs will increase in 2017, providing management time to adjust plans accordingly.

 

The balance of the summer will remain an important trading period, however assuming market conditions improve and our robust second half plans deliver, we expect to meet our profit expectations for the full year.

 

For more information, please contact:

A.G. BARR 01236 852400 Instinctif Partners 020 7457 2020

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next update: Interim Results - 27 September 2016

*Note: Like for like comparison excludes the sales revenue derived from the discontinued Orangina franchise in the corresponding period in 2015/16.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUGPRUPQGQG
Date   Source Headline
3rd Jun 20267:00 amRNS-RLaunch of IRN-BRU Summer Campaign
27th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSResult of AGM
11th May 20262:46 pmRNSDirector/PDMR Shareholding
21st Apr 202610:43 amRNSAnnual Report and Accounts and Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
13th Apr 20269:39 amRNSDirector/PDMR Shareholding
7th Apr 202611:21 amRNSDirector/PDMR Shareholding
1st Apr 20268:44 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSFinal Results
23rd Mar 20267:00 amRNS-RLaunch of IRN-BRU 'ZERO'
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSNotice of Results Presentation
9th Feb 20263:56 pmRNSDirector/PDMR Shareholding
4th Feb 20264:16 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSFull Year Trading Update
15th Jan 20267:00 amRNSDirectorate change
12th Jan 202611:00 amRNSDirector/PDMR Shareholding
8th Dec 20252:49 pmRNSDirector/PDMR Shareholding
19th Nov 20251:44 pmRNSHolding(s) in Company
17th Nov 20253:25 pmRNSDirector/PDMR Shareholding
10th Nov 20254:44 pmRNSDirector/PDMR Shareholding
10th Nov 20254:38 pmRNSDirector/PDMR Shareholding
8th Oct 20252:39 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSInterim Results
11th Sep 20252:00 pmRNSNotice of Results
10th Sep 20256:00 pmRNSDirector/PDMR Shareholding
28th Aug 20252:00 pmRNS2025 Annual General Meeting Update
12th Aug 20254:01 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSDirector Declaration
29th Jul 20257:00 amRNSTrading Statement
9th Jul 202511:00 amRNSAppointment of Non-Executive Director
8th Jul 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jul 202511:09 amRNSDirector/PDMR Shareholding
11th Jun 202511:01 amRNSDirector/PDMR Shareholding
10th Jun 20254:20 pmRNSDirector/PDMR Shareholding
10th Jun 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSCapital Markets Event
23rd May 20255:36 pmRNSResult of AGM
12th May 20251:54 pmRNSDirector/PDMR Shareholding
30th Apr 20259:15 amRNSPotential disposal of Strathmore Business
28th Apr 20253:16 pmRNSDirector/PDMR Shareholding
28th Apr 20253:15 pmRNSDirector/PDMR Shareholding
22nd Apr 202510:24 amRNSAnnual Financial Report
9th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20253:29 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSResults for year ended 25 January 2025
10th Mar 20252:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.